

Soligenix shares surged 72.32% in after-hours trading following rapid Bundibugyo virus vaccine development announcement.
You can purchase shares of Soligenix (NASDAQ:SNGX) through any online brokerage.
Other companies in Soligenix’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Soligenix has a consensus price target of $6.00.
The stock price for Soligenix (NASDAQ: SNGX) is $0.33 last updated November 10, 2026 at 11:11 AM EST.
There are no upcoming dividends for Soligenix.
Soligenix does not have any upcoming earnings scheduled.
There is no upcoming split for Soligenix.
Soligenix is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments...